Security key
37733W105
- Security type / class
- Equity / GSK
- Total 13F shares
- 316,555,475
- Total 13F value
- $11,315,271,578
- Share change
- +15,299,857
- Put/Call ratio
- 82%
- SEC-reported price per share
- $35.69
- Number of holders
- 764
- Value change
- +$543,119,017
- Number of buys
- 339
- Number of sells
- 374
Open additional details 1 more signal available
Report period
Q1 2021
Institutions
764
Top holders
10
GSK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
GSK plc SEC filings
GSK plc company facts
GSK plc 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 37733W105
Recent filing periods:
Ownership snapshot
Top reported holders of GSK - Glaxosmithkline Plc Adrf - GSK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DODGE & COX
Disclosed value leader
DODGE & COX
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $2,316,036,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
DODGE & COX has the largest disclosed position value at $2.32B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DODGE & COX's linked filing trail.
Disclosed position value
Top 5
DODGE & COX
$2.32B
FMR LLC
$712.49M
Capital International Investors
$648.41M
PRICE T ROWE ASSOCIATES INC /MD/
$608.9M
Fisher Asset Management, LLC
$608.18M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DODGE & COX |
13F
Company
|
—
denominator unverified
|
$2,316,036,000
62,935,758 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$712,486,000
19,361,008 shares
|
— | 31 Dec 2020 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$648,410,000
17,618,548 shares
|
— | 31 Dec 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$608,900,000
16,552,117 shares
|
— | 31 Dec 2020 |
| Fisher Asset Management, LLC |
13F
Company
|
—
denominator unverified
|
$608,179,000
16,526,594 shares
|
— | 31 Dec 2020 |
| ROYAL BANK OF CANADA |
13F
Company
|
—
denominator unverified
|
$541,391,000
14,711,762 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
764
Shares
316,555,475
Rows available
764
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q2 2026 Across Filers
Q2 2026 holders
4
Q1 2021 holders
764
Holder diff
760
| Investor | Q2 2026 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q2 2026 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend